Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Tags:
Cell Therapeutics
,
Momenta
,
Onyx
,
Amag Pharmaceuticals
,
Biomarin
,
M&A
,
Celgene
,
Seattle Genetics
,
Galena Biopharma
,
ImmunoCellular
,
Amgen
,
Celldex
,
Dendreon
,
GSK
,
Vical
,
Oncothyreon
,
Biogen Idec
,
Merck KGaA
,
Bristol-Myers Squibb
,
Allos
,
Spectrum Pharmaceuticals
,
AstraZeneca
A New CEO for AstraZeneca
Motley Fool
Tue, 08/28/12 - 10:55 am
Tags:
Pharma CEOs
,
AstraZeneca
,
Pascal Soriot
,
Roche
Merck's Blockbuster Drug Januvia And Its Competitors
Seeking Alpha
Tue, 08/28/12 - 10:54 am
Tags:
Merck
,
Januvia
,
diabetes
,
AstraZeneca
,
Bristol-Myers Squibb
,
JNJ
,
Novartis
,
Sanofi
,
Takeda
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Seeking Alpha
Mon, 08/27/12 - 05:27 pm
Tags:
Amylin
,
M&A
,
Bristol-Myers Squibb
,
Merck
,
Eli Lilly
,
AstraZeneca
,
diabetes
AstraZeneca Pays $26M To Settle Seroquel Suit
Pharmalot
Mon, 08/27/12 - 12:33 pm
Tags:
Seroquel
,
AstraZeneca
,
settlements
AstraZeneca In Strong Position With Brilinta
Seeking Alpha
Mon, 08/27/12 - 10:21 am
Tags:
Brilinta
,
AstraZeneca
,
Bristol-Myers Squibb
,
GSK
,
Sanofi
,
Human Genome Sciences
,
Medicines Company
Pfizer-AstraZeneca’s Nexium Deal. Win-Win for both Companies?
Motley Fool
Tue, 08/21/12 - 05:05 pm
Tags:
Pfizer
,
AstraZeneca
,
Nexium
AstraZeneca Wins This Summer's Pharma Acquisition Spree
Seeking Alpha
Sat, 08/18/12 - 04:03 pm
Tags:
AstraZeneca
AstraZeneca Wins This Summer's Pharma Acquisition Spree
Seeking Alpha
Fri, 08/17/12 - 11:34 am
Tags:
M&A
,
AstraZeneca
,
Bristol-Myers Squibb
,
JNJ
,
Verastem
,
Eli Lilly
,
Pfizer
The Men Who Run AstraZeneca
Motley Fool
Fri, 08/17/12 - 11:19 am
Tags:
AstraZeneca
3 Big Reasons To Buy AstraZeneca Today
Seeking Alpha
Fri, 08/17/12 - 10:29 am
Tags:
AstraZeneca
,
Eli Lilly
,
Novartis
,
GSK
,
Bristol-Myers Squibb
Alnylam, AstraZeneca form strategic alliance for microRNA
Yahoo/Fly on the Wall
Wed, 08/15/12 - 10:54 am
Tags:
microRNA
,
Alnylam
,
AstraZeneca
,
Regulus
7 Big-Pharma Stocks With Untapped Potential
TheStreet.com
Tue, 08/14/12 - 11:07 am
Tags:
GSK
,
JNJ
,
Bristol-Myers Squibb
,
Sanofi
,
AstraZeneca
,
Abbott Laboratories
,
Bayer
Novo Nordisk Still A Top-Notch Healthcare Growth Story
Seeking Alpha
Tue, 08/14/12 - 10:56 am
Tags:
Novo Nordisk
,
AstraZeneca
,
Bristol-Myers Squibb
,
Sanofi
,
Eli Lilly
Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium
Yahoo/AP
Tue, 08/14/12 - 10:54 am
Tags:
Pfizer
,
AstraZeneca
,
Nexium
,
OTC
AstraZeneca buys equal say over Amylin drugs
Reuters
Thu, 08/9/12 - 10:56 am
Tags:
Amylin
,
AstraZeneca
,
diabetes
,
Bristol-Myers Squibb
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Wed, 08/8/12 - 12:04 pm
Tags:
Pluristem
,
Amgen
,
AstraZeneca
,
Celgene
,
Dendreon
,
Eli Lilly
,
Medivation
,
Merck
,
Onyx
,
Pfizer
,
bone marrow disorder
Was MedImmune worth $15.6 billion?
Washington Post, DC
Mon, 08/6/12 - 11:44 am
Tags:
MedImmune
,
AstraZeneca
The Cheapest, Dividend-Paying Major Drug Manufacturers
Seeking Alpha
Fri, 08/3/12 - 11:13 am
Tags:
AstraZeneca
,
GSK
,
Eli Lilly
,
Sanofi
Vertex's Cystic Fibrosis Pipeline Offers Sales Upside
Seeking Alpha
Thu, 08/2/12 - 10:22 am
Tags:
cystic fibrosis
,
Vertex Pharma
,
AstraZeneca
,
Gilead
,
Kalydeco
,
Pfizer
,
Rigel Pharmaceuticals
,
VX-809
Pages
« first
‹ previous
…
121
122
123
124
125
126
127
128
129
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.